Amend Bill, page 3, line 6, by striking out "or
buprenorphine-related" and inserting
medication-related
Amend Bill, page 3, line 7, by inserting a bracket before
"for"
Amend Bill, page 3, line 7, by inserting a bracket after
"methadone-related"
Amend Bill, page 3, line 8, by striking out "or
buprenorphine-related" and inserting
medication-related
Amend Bill, page 3, line 8, by inserting a bracket before
"methadone-related"
Amend Bill, page 3, line 8, by inserting a bracket after
"methadone-related"
Amend Bill, page 3, lines 8 and 9, by striking out "or
buprenorphine-related" and inserting
medication-related
Amend Bill, page 4, by inserting between lines 6 and 7
(x) An office-based agonist treatment provider who
is assigned a waiver from the Drug Enforcement
Administration, including a special identification
number, commonly referred to as the "X" DEA number, to
provide office-based prescribing of buprenorphine.
(xi) A representative of the Department of Health
who is affiliated with the Achieving Better Care by
Monitoring All Prescriptions Program (ABC-MAP)
established under the act of October 27, 2014 (P.L.2911,
No.191), known as the Achieving Better Care by Monitoring
All Prescriptions Program (ABC-MAP) Act.
(xii) A toxicologist.
Amend Bill, page 4, line 10, by inserting after "each"
medication-related
Amend Bill, page 4, line 10, by inserting a bracket before
2019/90NAD/HB1662A02834 - 4 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33